Angel News

Angel News

Back to Homepage

23rd June 2020

Epidarex Capital closes £102m venture fund for life sciences

Epidarex Capital, a transatlantic life science venture firm, announces that it has closed Epidarex Capital III UK LP at £102.1 million. The Fund will build new life science companies based on world-class research and innovation from emerging hubs across the UK, including spinouts from highly regarded universities. Typical initial investments will range from £2 million to £5 million. 

...

Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:

Name:

Email:

Comment:

Enter the characters in the image shown:



Back to Homepage